| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | AMT | Nasdaq | $168.63 | $84.8B | $234.33 | $168.34 | Buy |
#2 | TRI | Nasdaq | $129.40 | $59.2B | $218.42 | $126.21 | Buy |
#3 | WDAY | Nasdaq | $207.23 | $56.7B | $283.68 | $202.22 | Buy |
#4 | ROP | Nasdaq | $434.71 | $48.0B | $595.17 | $427.89 | Buy |
#5 | WCN | Nasdaq | $166.28 | $43.1B | $201.66 | $163.27 | Strong Buy |
#6 | KR | Nasdaq | $59.43 | $40.0B | $74.90 | $58.12 | Buy |
#7 | VICI | Nasdaq | $27.77 | $32.4B | $34.03 | $27.48 | Buy |
#8 | CSGP | Nasdaq | $58.46 | $28.8B | $97.43 | $60.19 | Buy |
#9 | TW | Nasdaq | $103.84 | $22.9B | $152.65 | $101.71 | Buy |
#10 | SBAC | Nasdaq | $181.06 | $20.2B | $245.16 | $180.11 | Buy |
#11 | GDDY | Nasdaq | $113.69 | $17.2B | $216.00 | $114.36 | Buy |
#12 | GFL | Nasdaq | $42.52 | $16.2B | $52.00 | $41.29 | Buy |
#13 | DOCS | Nasdaq | $43.97 | $12.3B | $85.21 | $43.21 | Buy |
#14 | DLB | Nasdaq | $64.34 | $6.4B | $89.66 | $63.14 | Strong Buy |
#15 | CALM | Nasdaq | $73.46 | $4.2B | $126.40 | $74.74 | Buy |
#16 | ODD | Nasdaq | $35.39 | $3.8B | $79.18 | $35.30 | Buy |
#17 | TLX | Nasdaq | $7.55 | $3.3B | $30.36 | $7.38 | Strong Buy |
#18 | MNR | Nasdaq | $10.82 | $2.1B | $19.00 | $10.79 | Strong Buy |
#19 | FVRR | Nasdaq | $18.16 | $754.2M | $35.45 | $18.25 | Strong Buy |
The FinQuota filters have identified what they believe to be the "NASDAQ 52 Week Low Stocks (January 10, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.